The reversal of drug-resistance in tumors using a drug-carrying nanoparticular system

34Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

Medical applications of nanoparticular systems have attracted considerable attention because of their potential use in therapeutic targeting of disease tissues and their lower level of toxicity against healthy tissue, relative to traditional pharmaceutical drugs. The use of nanoparticular systems has been shown to overcome the limitations of most anticancer drugs in clinical applications. In particular, the improved performance of smarted nanoparticular system for solving the drug resistance problems that typically interrupt tumor treatment has provided a promising strategy for successful tumor chemotherapy. This review highlights recent studies that have examined the therapeutic effect of nanoparticular systems on drug-resistant tumors and presents insight on how they work. © 2009 by the authors; licensee Molecular Diversity Preservation International.

Cite

CITATION STYLE

APA

Kyung, T. O., Hye, J. B., A, H. L., Young, T. O., Yu, S. Y., & Eun, S. L. (2009, September). The reversal of drug-resistance in tumors using a drug-carrying nanoparticular system. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms10093776

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free